Changes in neuroactive steroid secretion associated with CO2-induced panic attacks in normal individuals

Psychoneuroendocrinology

Volumn 38, Issue 10, 2013, Pages 2234-2242

  Brambilla, Francesca ^a   Perini, Giulia ^b   Serra, Mariangela ^c   Pisu, Maria Giuseppina ^d   Zanone, Stefano ^b   Toffanin, Tommaso ^b   Milleri, Stefano ^e   Garcia, Cristina Segura ^f   Biggio, Giovanni ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY OF CAGLIARI   (Italy)

^d CNR Consiglio Nazionale delle Ricerche   (Italy)

^e G B ROSSI UNIVERSITY HOSPITAL   (Italy)

^f UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

3 ,5 Tetrahydrodesoxycorticosterone; 3 ,5 Tetrahydroprogesterone; CO2 inhalation; Cortisol; Dehydroepiandrosterone; Panic attack; Progesterone

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 3ALPHA,5ALPHA TETRAHYDRODESOXYCORTICOSTERONE; CARBON DIOXIDE; HYDROCORTISONE; NEUROSTEROID; PRASTERONE; PROGESTERONE; TETRAHYDRODEOXYCORTICOSTERONE; UNCLASSIFIED DRUG;

ADULT; ANDROGEN BLOOD LEVEL; ANXIETY; ARTICLE; BEHAVIOR CHANGE; CARBON DIOXIDE BREATHING; CONTRACEPTION; CONTROLLED STUDY; FEMALE; FOLLICULAR PHASE; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; LUTEAL PHASE; MALE; NORMAL HUMAN; OUTCOME ASSESSMENT; PANIC; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PSYCHOLOGIC ASSESSMENT; STEROID RELEASE; SYMPTOMATOLOGY;

3Α,5Α-TETRAHYDRODESOXYCORTICOSTERONE; 3Α,5Α-TETRAHYDROPROGESTERONE; CO(2) INHALATION; CORTISOL; DEHYDROEPIANDROSTERONE; PANIC ATTACK; PROGESTERONE;

ADULT; CARBON DIOXIDE; FEMALE; HUMANS; INHALATION EXPOSURE; MALE; MENSTRUAL CYCLE; MIDDLE AGED; NEUROTRANSMITTER AGENTS; PANIC DISORDER; STEROIDS; YOUNG ADULT;

EID: 84883877071     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2013.04.008     Document Type: Article

References (62)

1. Agis-Balboa R.C., Pinna G., Zhubi A., Maloku E., Veldic M., Costa E., Guidotti A. Characterization of brain neurons that express enzyme mediating neurosteroid biosynthesis. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:14602-14607.
2. Agis-Balboa R.C., Pinna G., Pibiri F., Kadriu B., Costa E., Guidotti A. Down-regulation of neurosteroid biosynthesis in corticolimbic circuits mediates social isolation-induced behaviour in mice. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:18736-18741.
3. Akk G., Shu H.J., Wang C., Steinbach J.H., Korumski C.F., Covey D.F., Mennerick S. Neurosteroid access to the GABA(A) receptor. J. Neurosci. 2005, 25:11605-11613.
4. Akwa Y., Purdy R.H., Koch G.F., Britton K.T. The amygdala mediates the anxiolytic effect of the neurosteroid allopregnanolone in rat. Behav. Brain Res. 1999, 106:119-125.
5. American Psychiatric Association DSM-IV, Diagnostic and Statistical Manual of Disorders 1994, American Psychiatric Press, Washington, DC. IV ed. rev.
6. Bandelow B., Wedekind D., Pauls J., Brooks A., Hajak G., Ruther E. Salivary cortisol in panic attacks. Am. J. Psychiatry 2000, 157:456.
7. A receptor function after acute stress. Neuroendocrinology 1996, 63:166.
8. Barbaccia M.L., Lello S., Sidiropoulou T., Cocco T., Sorge S.P., Cocchiarale A., Piermarini V., Sabato A.F., Trabucchi M., Romanici C. Plasma 5α-androstane-3α,17βdiol, an endogenous steroid that positively modulates GABA receptor function and anxiety: a study in menopausal women. Psychoneuroendocrinology 2000, 25:659-675.
9. 2 challenge in panic disorder: optimization by receiver operating characteristic (ROC) analysis. J. Psychiatr. Res. 1995, 29:111-119.
10. Battaglia M., Ogliari A., Harris J., Spatola C.A.M., Pesenti-Gritti P., Reichborn-Kjennerud T., Torgersen S., Kringlen E., Tambs K. A genetic study of the acute anxious response to carbon dioxide stimulation in man. J. Psychiatr. Res. 2007, 41:906-917.
11. 2, panic disorder, and the effect of childhood parental loss. Arch. Gen. Psychiatry 2009, 66:64-71.
12. Beaulieu E.E. Neurosteroids: a novel function of the brain. Psychoneuroendocrinology 1998, 23:114-119.
13. Bicikova M., Tallova J., Hill M., Rausova Z., Hampl R. Serum concentrations of some neuroactive steroids in women suffering from mixed anxiety-depressive disorder. Neurochem. Res. 2000, 12:1623-1627.
14. Bitran D., Klibanski D.A., Martin G.A. The neurosteroid pregnanolone prevents the anxiogenic-like effect of inescapable shock in the rat. Psychopharmacology (Berlin) 2000, 151:31-37.
15. Brambilla F., Biggio G., Pisu M.G., Bellodi L., Perna G., Bogdanovich-Djukic V., Purdi R.H., Serra M. Neurosteroid secretion in panic disorder. Psychiatry Res. 2003, 118:107-116.
16. Brambilla F., Biggio G., Pisu M.G., Purdy R.H., Gerra G., Zaimovich A., Serra M. Plasma concentrations of anxiolytic neurosteroids in men with normal anxiety scores: a correlation analysis. Neuropsychobiology 2004, 50:6-9.
17. Brambilla F., Mellado C., Alciati A., Pisu M.G., Purdy R.H., Zanone S., Perini G., Serra M.R., Biggio G. Plasma concentrations of anxiolytic neuroactive steroids in men with panic disorder. Psychiatry Res. 2005, 135:185-190.
18. A receptors. Eur. J. Pharmacol. 1997, 325:1-7.
19. Cameron O.G., Lee M.A., Curtis G.C., McCann D.S. Endocrine and physiological changes during "spontaneous" panic attacks. Psychoneuroendocrinology 1987, 12:321-331.
20. Concas A., Mostallino P.C., Porcu P., Follesa P., Barbaccia M., Trabucchi M., Purdy R., Grisenti P., Biggio G. Role of brain allopregnanolone in the plasticity of γ-aminobutyric acid type A receptor in rat brain during pregnancy and after delivery. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:13284-13289.
21. 2 inhalation in subjects at high risk for panic disorder. Biol. Psychiatry 2004, 55:1S-1225S.
22. Dell'Osso I., Carmassi C., Da Pozzo E., Mundo F., Martini C. Correlations between cortisol and DHEAS levels and subthreshold panic-agoraphobic spectrum symptoms in healthy subjects. World Psychiatry 2009, 8:51.
23. Engel S.R., Grant K.A. Neurosteroids and behaviour. Int. Rev. Neurobiol. 2001, 46:321-348.
24. Eser D., Di Michele F., Zwanger P., Pasini A., Baghai T.C., Schule C., Rupprecht R., Romeo E. Panic induction with cholecystokinin-tetrapeptide (CCK-4) increases plasma concentrations of the neuroactive steroid 3α-5α-tetrahydrodeoxycorticosterone (3α-5α-THDOC) in healthy volunteers. Neuropsychopharmacology 2005, 30:192-195.
25. 2. J. Psychopharmacol. 2009, 23:975-978.
26. Gartside S.E., Griffith N.C., Kaura V., Ingram C.D. The neurosteroid deidroepiandrosterone (DHEA) and its metabolites altered 5-HT neuronal activity via modulation of GABAA receptors. Psychopharmacology 2010, 24:1717-1724.
27. Gorman J.M., Battista D., Goetzn R.R., Dillon D.J., Liebowitz M.R., Fyer A.J., Kahn J.P., Sandberg D., Klein D.F. A comparison of sodium bicarbonate and sodium lactate infusion in the induction of panic attacks. Arch. Gen. Psychiatry 1989, 46:145-150.
28. Gorman J.M., Papp L.A., Martinez J., Goetz R.R., Hollander E., Liebowitz M.R., Jordan F. High-dose carbon dioxide challenge test in anxiety disorder patients. Biol. Psychiatry 1990, 28:743-757.
29. Heydary B., Le Mellado J.W. Low pregnenolone sulphate plasma concentrations in patients with generalized social phobia. Psychol. Med. 2002, 32:929-933.
30. Hollander E., Liebowitz M.R., Gorman J.M., Cohen B., Fyer A., Klein D.F. Cortisol and sodium lactate-induced panic. Arch. Gen. Psychiatry 1989, 46:135-140.
31. Levin A.P., Doran A.R., Liebowitz M.R., Fyer A.J., Gorman J.M., Klein D.F., Paul S.M. Pituitary adrenocortical unresponsiveness in lactate-induced panic. Psychiatry Res. 1987, 21:23-32.
32. Levine S. Influence of psychological variables on the activity of the hypothalamic-pituitary-adrenal axis. Eur. J. Pharmacol. 2000, 405:149-160.
33. McEwen B.S. Protective and damaging effects of stress mediators. N. Engl. J. Med. 1998, 338:171-179.
34. Patchev V.K., Hassan A.H., Holsboer D.F., Almeida O.F. The neurosteroid tetrahydroprogesterone counteracts corticotropin-releasing hormone-induced anxiety and alters the release and gene expression of corticotropin-releasing hormone in the hypothalamus. Neuroscience 1994, 62:265-271.
35. Paul S.M., Purdy R.H. Neuroactive steroids. FASEB J. 1992, 6:2311-2322.
36. 2 in healthy first degree relatives of patients with panic disorder. Am. J. Psychiatry 1995, 152:623-625.
37. 2 e polimorfismi della regione regolatoria del gene del trasportatore della serotonina nel disturbo di panico. Ital. J. Psychopathol. 2003, 9:31.
38. Petrowski K., Herold U., Joraschky P., Wittchen H.U., Kirschbaum C. A striking pattern of cortisol non-responsiveness to psychosocial stress in patients with panic disorder with concurrent normal cortisol awakening responses. Psychoneuroendocrinology 2010, 35:414-421.
39. Pinna G., Agis-Balboa R.C., Pibiri F., Nelson M., Guidotti A., Costa E. Neurosteroid biosynthesis regulates sexual dimorphic fear and aggressive behavior in mice. Neurochem. Res. 2008, 33(10):1990-2007.
40. Pisu M.G., Serra M. Neurosteroids and neuroactive drugs in mental disorders. Life Sci. 2004, 74:3181-3197.
41. Pols H., Zandberg J., de Loof C., Griez E. Attenuation of carbon dioxide-induced panic after clonazepam treatment. Acta Psychiatr. Scand. 1991, 84:585-586.
42. Purdy R.H., Morrow A.L., Plinn J.R., Paul S.M. Synthesis, metabolism and pharmacological activity of 3α-hydroxysteroids which potentiate GABA-receptor-mediated chloride ion uptake in rat cerebral cortical synaptoneurosomes. J. Med. Chem. 1991, 33:1572-1581.
43. Rupprecht R. Induced panic attacks shift γ-aminobutyric acid type A receptor modulatory neuroactive steroid composition in patients with panic disorder: preliminary results. Arch. Gen. Psychiatry 2003, 60:161-168.
44. Rupprecht R., Holsboer F. Neuroactive steroid mechanisms of action and neuropsychopharmacological perspectives. Trends Neurosci. 1999, 22:410-416.
45. Rupprecht R., Di Michele F., Herman B., Strohle A., Lancel M., Romeo H., Holsboer F. Neuroactive steroids: molecular mechanisms of action and implications for neuropsychopharmacology. Brain Res. Rev. 2001, 37:59-67.
46. 2 challenge reactivity as unique and interactive prospective predictors of anxiety pathology. Depress. Anxiety 2007, 24:527-536.
47. Seier F.E., Kellner M., Yassouridis A., Heese R., Strian F., Wiedemann K. Autonomic reactivity and hormonal secretion in lactate-induced panic attacks. Am. J. Physiol. 1997, 272:2630-2638.
48. Serra M., Madau P., Chessa M.F., Caddeo M., Sanna E., Trapani G., Franco M., Liso G., Purdy R.H., Barbaccia M.L., Biggio G. 2-Phenyl-imidazo[1,2-a]pyridine derivative as ligands for peripheral benzodiazepine receptors: stimulation of neurosteroid synthesis and anticonvulsant action in rat. Br. J. Pharmacol. 1999, 127:177-187.
49. Semeniuk I., LeMelledo J.M., Shangri G.S. Neuroactive steroid levels in patients with generalized anxiety disorders. J. Neuropsychiatry Clin. Neurosci. 2001, 13:396-398.
50. Sheehan D.V., Lecrubier Y., Janays J., Knapp E., Werler E., Bonora P., Sheedan M., Amorim P., Baker M., Sheehan K.H., Lepine J.P. MIINI-International Neuropsychiatric Interview 1994, Tampa, Paris.
51. A-antagonistic neurosteroids in patients with combat-related post-traumatic stress disorder. Psychol. Med. 2000, 30:1227-1231.
52. A receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment. Am. J. Psychiatry 2002, 159:145-147.
53. Strohle A., Romeo E., Di Michele F.A., Pasini A., Hermann B., Gajewsky G., Holsboer R., Rupprecht R. Induced panic attacks shift gamma-aminobutyric acid type A receptor modulatory neuroactive steroid composition in patients with panic disorder. Preliminary results. Arch. Gen. Psychiatry 2003, 60:161-168.
54. Tait G.R., McManus K., Bellavance F., Lara N., Chrapko W., Le Melledo J.M. Neuroactive steroid changes in response to challenge with the panicogenic agent pentagastrin. Psychoneuroendocrinology 2002, 27:417-429.
55. Toru I., Aluoja A., Vohma U., Raag M., Vasar V., Maron E., Shlik J. Association between personality traits and CCK-4-induced panic attacks in healthy volunteers. Psychiatry Res. 2010, 178:342-347.
56. Ursin H., Baade E., Levine S. Psychobiology of Stress 1978, Academic Press, New York.
57. Van Duinen M.A., Schruers K.K., Jaegers E., Maes M., Griez E.J. Salivary cortisol in panic: are males more vulnerable?. Neuroendocrinol. Lett. 2004, 25:386-390.
58. Wieland S., Lan N.C., Miradeseghi S., Gee K.W. Anxiolytic activity of the progesterone metabolite 5α-pregnan-3α-ol-20-one. Brain Res. 1991, 565:263-268.
59. Woods S.W., Charney D.S., McPerson C.A., Gradman A.H., Heninger G.R. Situational panic attacks: behavioural, physiologic and biochemical characterization. Arch. Gen. Psychiatry 1987, 44:365-375.
60. Zinbarg R.E., Brown T.A., Barlow D.H., Rapee R.M. Anxiety sensitivity, panic, and depressed mood: a reanalysis teasing apart the contribution of the two levels in the hierarchical structure of the Anxiety Sensitivity Index. J. Abnorm. Psychol. 2001, 10:172-177.
61. Zwanzger P., Baghai T.C., Schuele C., Strohle A., Padberg F., Kathmann N., Schwarz M., Moller H.J., Rupprecht R. Vibagastrin decreases cholecystokinin-tetrapeptide (CCK-4) induced panic in healthy volunteers. Neuropsychopharmacology 2001, 25:699-703.
62. Zwanzger P., Eser D., Padberg F., Baghai T.C., Schule C., Rupprecht R. Neuroactive steroids are not affected by panic induction with 50μg cholecystokinin-tetrapeptide (CCK-4) in healthy volunteers. J. Psychiatr. Res. 2003, 38:215-217.